Red Light Holland Corp. (TRUFF)
OTCMKTS · Delayed Price · Currency is USD
0.0256
-0.0054 (-17.45%)
Aug 1, 2025, 3:15 PM EDT
HashiCorp Revenue
In the fiscal year ending March 31, 2025, Red Light Holland had annual revenue of 4.94M CAD with 4.05% growth. Red Light Holland had revenue of 849.41K in the quarter ending March 31, 2025, a decrease of -33.43%.
Revenue
4.94M CAD
Revenue Growth
+4.05%
P/S Ratio
3.47
Revenue / Employee
47.54K CAD
Employees
104
Market Cap
11.95M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.94M | 192.40K | 4.05% |
| Mar 31, 2024 | 4.75M | 802.31K | 20.31% |
| Mar 31, 2023 | 3.95M | 1.62M | 69.84% |
| Mar 31, 2022 | 2.33M | 2.21M | 1,995.96% |
| Mar 31, 2021 | 110.96K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Red Light Holland News
- 4 days ago - Red Light Holland CEO Todd Shapiro Invited by Blockchain Futurist Conference for Fireside Chat and Panel Hosting - Newsfile Corp
- 5 days ago - Red Light Holland reports FY results - Seeking Alpha
- 5 days ago - Red Light Holland Reports 2025 Audited Year-End Results - Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion - Newsfile Corp
- 6 days ago - Red Light Holland Provides Timing for 2025 Audited Year-End Results and Announces Live Q&A - Newsfile Corp
- 9 days ago - Red Light Holland Selects Arch Public for Bitcoin Purchases on Recommendation from Advisor Scott Melker - Newsfile Corp
- 19 days ago - Red Light Holland Announces Bitcoin Balance Sheet Strategy and Names Scott Melker as Lead Cryptocurrency Advisor - Newsfile Corp
- 20 days ago - Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives First Global Shipment of Psilocybin from Company's Netherlands Facility via USA Controlled Substances Permit - Newsfile Corp
- 4 weeks ago - Red Light Holland Announces Dr. Robin Carhart-Harris as Scientific Advisor - Newsfile Corp